Elise P.
- Country
- France
- Department
- Ophtalmologie
Research Overview
- Randomized, Double-Masked, Multicenter Phase 2/3 Trial of Intravitreal MK-8748 Versus Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration
- Evaluation of Faricimab Efficacy and Safety in Neovascular Age-Related Macular Degeneration: A Phase IIIb/IV Multicenter, Randomized, Open-Label Study
- Efficacy and Safety Evaluation of Intravitreal EYE103 Versus Ranibizumab in Diabetic Macular Edema: A Randomized, Double-Masked, Phase 2/3 Study
Data & Insights
Has run more than one trial at 42 of 96 partner sites.
Specializations
Diabetic Macular Edema
Clinical research in diabetic macular edema centers on intravitreal treatment strategies aimed at preserving and improving best-corrected visual acuity in patients with vision loss from retinal swelling.
- Intravitreal therapy for retinal fluid control
- Visual acuity preservation in macular disease
- Anti-VEGF comparative effectiveness
The therapeutic focus includes evaluation of novel ocular treatments against established anti-VEGF approaches in retinal vascular disease.
Geographic Atrophy Secondary to Age-Related Macular Degeneration
Research activity in geographic atrophy addresses progressive retinal degeneration associated with age-related macular degeneration, with attention to long-term ocular safety and maintenance of central vision.
- Geographic atrophy management
- Retinal degeneration in AMD
- Long-term intravitreal safety
Therapeutic interest extends to emerging approaches for slowing structural retinal loss in dry AMD and related atrophic disease.
Neovascular Age-Related Macular Degeneration
Clinical involvement in neovascular age-related macular degeneration is focused on intravitreal treatment options that support sustained vision outcomes in exudative retinal disease.
- Anti-angiogenic ocular therapy
- Neovascular retinal disease
- Durability of visual response
This area includes assessment of newer agents for wet AMD and their role in maintaining retinal function over time.
Macular Edema Secondary to Retinal Vein Occlusion
Work in macular edema secondary to retinal vein occlusion addresses vision impairment caused by venous obstruction and associated macular swelling, with emphasis on restoring retinal anatomy and function.
- Retinal vein occlusion treatment
- Macular swelling and vision loss
- Intravitreal biologic therapies
The therapeutic landscape reflects interest in optimizing ocular injections for retinal edema linked to vascular occlusive disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.